Back to mobile site

Valeant (VRX) Continues Deal Hunt; Close to Buying Bausch & Lomb for $9B

May 24, 2013 12:50 PM EDT Send to a Friend
Shares of Valeant Pharmaceuticals International (NYSE: VRX) surged 10 percent higher mid-day Friday on reports the company has a new ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login